Parietal operculum and motor cortex activities predict motor recovery in moderate to severe stroke

Autor: Firdaus Fabrice Hannanu, Thomas A. Zeffiro, Laurent Lamalle, Olivier Heck, Félix Renard, Antoine Thuriot, Alexandre Krainik, Marc Hommel, Olivier Detante, Assia Jaillard, K. Garambois, M. Barbieux-Guillot, I. Favre-Wiki, S. Grand, J.F. Le Bas, A. Moisan, M.J. Richard, F. De Fraipont, J. Gere, S. Marcel, W. Vadot, G. Rodier, D. Perennou, A. Chrispin, P. Davoine, B. Naegele, P. Antoine, I. Tropres, F. Renard

Publikováno v: NeuroImage: Clinical, Vol 14, Iss C, Pp 518-529 (2017)

While motor recovery following mild stroke has been extensively studied with neuroimaging, mechanisms of recovery after moderate to severe strokes of the types that are often the focus for novel restorative therapies remain obscure. We used fMRI to:

Externí odkaz: https://doaj.org/article/bada125cc4534465a38024147827c356

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Autor: Denis Moro-Sibilot, Renaud Sabatier, Alexis B. Cortot, Gérard Zalcman, S.D. Guibert, Fabrice Barlesi, Maurice Pérol, J. Otto, Ratislav Bahleda, Gilles Vassal, P.J. Souquet, Marta Jimenez, Nathalie Cozic, Gilbert Ferretti, Bertrand Mennecier, N. Hoog-Labouret, S. Bota, Marie Wislez, F. De Fraipont, Véronique Haddad, Julien Mazieres, C. Dubos, V. Verriele, Isabelle Monnet

Publikováno v: Annals of Oncology
Annals of Oncology, 2019, 30 (12), pp.1985-1991. ⟨10.1093/annonc/mdz407⟩
Annals of Oncology, Elsevier, 2019, 30 (12), pp.1985-1991. ⟨10.1093/annonc/mdz407⟩

Background In 2013, the French National Cancer Institute initiated the AcSe program to provide patients with secure access to targeted therapies outside of their marketed approvals. Efficacy and safety was then assessed using a two-stage Simon phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487217358f47df224fa568af23e7e11c
https://hal.science/hal-02530381

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Détection des variants de fusion du gène ALK par séquençage massif parallèle ciblé à partir d’ARN et réponse au crizotinib dans les cancers pulmonaires non à petites cellules

Autor: M. Giaj Levra, Julien Fauré, Julie Mondet, Elizabeth Brambilla, M. Phillips Houlbracq, Michael Duruisseaux, F. De Fraipont, D. Moro-Sibilot, Gilbert Ferretti, Sylvie Lantuejoul, Pierre Hainaut, J. Pinsolle, Amandine Chatagnon, Anne-Claire Toffart, Nelly Magnat, A. Mcleer

Publikováno v: Revue des Maladies Respiratoires. 35:A7-A8

Introduction Differents variants de fusion ont ete decrits dans les rearrangements du gene ALK au sein des cancers pulmonaires non a petites cellules (CPNPC) et influeraient sur la sensibilite cellulaire au traitement par crizotinib. Le but de cette

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0adabf6e2444ca1fed58c6ea0accbcfd
https://doi.org/10.1016/j.rmr.2017.10.019